Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Nanoviricides, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 30 | 31 | +1 |
| Shares | 1.36M | 1.25M | −110.8K (−8.1%) |
| Value | $1.51M | $1.47M | −$44.6K (−2.9%) |
New holders (4)
Institutions that held Nanoviricides, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 14,153 | $16.6K | 0.00% |
| Stifel Financial Corp | 11,500 | $13.5K | 0.00% |
| Cary Street Partner Investment Advisory LLC | 15 | $18 | 0.00% |
| FMR LLC | 1 | $1 | 0.00% |
Sold out (3)
Institutions that held Nanoviricides, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Two Sigma Securities, LLC | 13,410 | $14.9K |
| Virtu Financial LLC | 11,587 | $13.0K |
| UBS Group AG | 7,406 | $8.22K |